Garcia
The field of cancer immunotherapy has witnessed a paradigm shift with the advent of allogeneic chimeric antigen receptor (CAR) natural killer (NK) cell therapies. These off-the-shelf therapeutic products offer a promising alternative to traditional autologous CAR-T therapies, addressing several limitations and extending the benefits of immunotherapy to a broader patient population.
- Followers
- 0
- Datasets
- 0
- Edits
- 0
- Username
- catalinagarcia
- Member Since
- February 25, 2025
- State
- active
